Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone addition for rebound pain after single-shot nerve block with ropivacaine
ChiCTR-IPR-17011365Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in postoperative pain (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: breakthrough pain after surgery, total consumption of morphine and 3 more. Started Jul 2016; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR-IPR-17011365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011365.